I Trephine biopsy o f t e t r a c y c l i n e l a b e l e d bone, p a r a t h y r o i d
hormone l e v e l s and bone densitometry u s i n g photon absorpt i o m e t r y were accomplished i n a 14-year-old g i r l w i t h 45,X karyotype who a l s o has a craniopharyngioma. A t t h e t i m e o f t h e i n i t i a l s t u d i e s , she was t a k i n g replacement h y d r o c o r t isone, 10mg. every morning and 5mg. a t n i g h t and 150mcg. o f Thyroxine d a i l y . The c e l l and t i s s u e l e v e l dynamics o f bone r e m o d e l l i n g were e l e v a t e d and s l i g h t l y above normal compatible w i t h h i g h t u r n o v e r bone. I n r e t r o s p e c t t h i s may have been r e l a t e d t o t h e s l i g h t l y h i g h t h y r o x i n e replacement dose. F o l l o w i n g e i g h t months o f growth hormone treatment, t h e dynamics showed f u r t h e r i n c r e a s e i n bone a c t i v i t y a t b o t h t h e haversian and e n d o s t e a l -c o r t i c a l surfaces. The t h y r o x i n e replacement remained constant. She grew t h r e e inches, whereas she had p r e v i o u s l y o n l y grown 4 i n c h per year. The parat h y r o i d hormone l e v e l s d i d n o t change s i g n i f i c a n t l y . The bone densitometry was 7 standard d e v i a t i o n s below normal f o r age and sex and d i d n o t change s i g n i f i c a n t l y w i t h treatment. Calcium (Ca) disorders and therapeutic effectiveness can be assessed by measurements of bone dynamics using stable tracer me. thods. A pulse of IV Ca-46 is followed by a 9-15 day continuous feeding of Ca-48. Ca isotopic abundances in serum, urine, and feces are determined by thermoionization mass spectrometry (0.5% precision). Kinetic parameters (mg/kg/d) are calculated by nonlinear, weighted least squares analysis and growth is compensate' for by using expanding pool sizes. Two infants (Inf.) had Ca turnover rates 12 times that of a control adult (Ad); bone Ca deposition (v0+) and resorption (v ) were determined with 2 to 5% precision. Two infants with osfe~~enesis imperfecta (01) wer studied before (B) and while taking ascorbic acid ( C ) . ---..
a rash at birth which evolved to generalized calcified nodules and plaques. Extensive investigation ruled out known causes of dystrophic calcification. Skin biopsy revealed osteoblast-like cells (OB) surrounding an osteoid layer at the surface of dysplastic woven bone containing osteocytes (OC). Electron microscopy (EM) showed that the OB more closely resembled fibroblasts and the OC appeared to be non-functional. Alkaline phosphatase (AP) was identified by EM techniques in the outer surface of the fibroblast cell membrane 5 microns from the mineralizing front C fibrous bone and along collagen fibers. X-ray microanalysis of the woven bone revealed mineral composition (Ca 41%; P 19%) similar to notmal bonehut less dense. Skin fibroblasts in vit1 pparently transfomed to OB after the 4th passage as evidenced y positive Von Kossa staining, high AP activity (201 unitslmg rotein with 70% heat labile), and morphological appearance. S p e c i f i c 1251 i n s u l i n b i n d i n g t o c i r c u l a t i n g monocytes was s t u d i e d i n a group o f 13 p a t i e n t s w i t h CF, 4 o f whom were i n s u l i dependent. Nine u n t r e a t e d p a t i e n t s had m i l d carbohydrate i n t o lerance i n response t o o r a l glucose as compared t o c o n t r o l s (201f 26mg/dl vs.103*6 M~s E~ a t 2h; 144*26 vs.92*5 a t 3h). The peak i n s u l i n response was delayed t o 2 hours i n CF and lower than t h e one hour peak o f normals (44mIU/ml vs.66mIU/ml). C a l c u l a t e d i ns u l inogenic index, I 1 (ZAinsul in/ZAglucose) was lower f o r CF t h a c o n t r o l s (0.21*0.05 vs.D.37fD.04 p<0.01), i n d i c a t i n g enhanced i n s u l i n s e n s i t i v i t y . Scatchard a n a l y s i s o f i n s u l i n b i n d i n g r evealed a marked increase i n r e c e p t o r s i t e s i n u n t r e a t e d CF pat i e n t s as compared t o c o n t r o l s ; 44,000 s i t e s / c e l l vs. 25,000 s i t e s / c e l l . S p e c i f i c i n s u l i n b l n d i n g a t t r a c e r c o n c e n t r a t i o n s (0.3ngIml) was lower i n CF 3.14% vs.5.14%, and t h e c a l c u l a t e d a f f i n i t y c o n s t a n t f o r b i n d i n g (Ke) was reduced, 0 . 8~1 0 8 ?4-1 vs. 2 . 5~1 0 8 M-1. I n s u l i n t r e a t e d p a t i e n t s d i d n o t have lower recept o r numbers o r a l t e r e d a f f i n i t y as compared t o t h e untreated.
Thus 1 ) i n CF diminished i n s u l i n s e c r e t i o n i s a s s o c i a t e d w i t h an
increased number o f r e c e p t o r s i t e s 2 ) increased b i n d i n g s i t e s would e x p l a i n s e n s i t i v i t y t o endogenous i n s u l i n , as demonstrated by t h e decreased I 1 as w e l l as t o exogenous i n s u l i n ( r e p o r t e d by others) 3 ) t h e consequences o f t h e s u b s t a n t i a l increase i n recept o r number may be o f f s e t somewhat by reduced r e c e p t o r a f f i n i t y . Our previous observation that ZnSOq, added in vitro, both stimulated and stabilized residual leukocyte acidic a-mannosidase activity in two patients (Arch. Neurol. 34, 45, 1977) prompted a therapeutic trial of the metal. Oral ZnSOq in doses ranging from 13-45 mg/kg over a 12-week period raised serum Zn levels to a maximum of twice normal. Average leukocyte acid a-mannosidase activity during the treatment period ranged from 2-5% of control values, showing no significant difference from baseline levels. No treatment related change occurred in the 11 band thin layer chromatographic profile of mannose containing neutral oligosaccharides excreted in a 24-hour urine. Because Zn is known to have a high affinity for tissue uptake, 1 ml containing 10 mg ZnS04 was injected into the gingiva of patient 1, which had become hyperplastic with PAS-positive storage material. A control site was injected with an equal volume of saline. Biopsies before and one month after the injections showed no change in the ultrastructural characteristics of membrane bound cytoplasmic vacuoles. The Zn injected tissue had a moderately increased amount of collagenous stroma, which was not seen in either the saline or pre-injection controls. This may reflect a positive effect on wound healing. Otherwise, ZnSOq does not appear to have specific therapeutic efficacy in ameliorating storage material in mannosidosis under the above conditions. 
